Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Consolidated Net Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Consolidated Net Profit ₹35 Cr₹-67 Cr₹1,174,569 Cr₹9.20 Cr₹9.20 Cr

What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?

The latest Consolidated Net Profit ratio of NATH BIOGENES (INDIA) is ₹35 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹35 Cr
Mar2023₹-67 Cr
Mar2022₹1,174,569 Cr
Mar2013₹9.20 Cr
Mar2012₹9.20 Cr

How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹35 Cr
Positive
Mar2023 ₹-67 Cr
Negative
Mar2022 ₹1,174,569 Cr
12,765,571.01
Mar2013 ₹9.20 Cr
0.00
Mar2012 ₹9.20 Cr -

Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹330.1 Cr -1.4% -12.9% -14% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹17,186.9 Cr -3.9% -6.7% 67.7% Stock Analytics
KAVERI SEED COMPANY ₹4,228.8 Cr -4% -4.8% 38.4% Stock Analytics
VENKYS (INDIA) ₹2,381.6 Cr -1.3% -1.2% -15.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,464.9 Cr -7.3% -13.4% -38.7% Stock Analytics
TIERRA AGROTECH ₹397.4 Cr 1.3% -1.2% -39.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1.4%

-12.9%

-14%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses